Legal Representation
Attorney
Larisa R Lacis
USPTO Deadlines
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 9, 2008 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 9, 2008 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 9, 2008 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 9, 2008 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 9, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 7, 2007 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 7, 2007 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 10, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 17, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 28, 2007 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Mar 22, 2007 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 22, 2007 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 27, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 27, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 23, 2007 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 17, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 8, 2006 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Nov 7, 2006 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research services in the field of cancer treatment and diagnosis; Medical and scientific research, namely conducting clinical trials; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Research and development and consultation related thereto in the field of cancer drugs for therapeutical applications; Research and development of vaccines and medicines; Research on the subject of pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a triangle pointing downwards and comprised of five gray circles and one orange circle as the bottom circle.
Color Claim
The color(s) gray and orange is/are claimed as a feature of the mark.
Classification
International Classes
042